支持医保知证决策的降糖新药多维价值评估框架研究
中图分类号R977.1+5 文献标志码A 文章编号1001-0408(2025)13-1563-05DOI 10.6039/j.issn.1001-0408.2025.13.02
on the multi-dimensional value assessment framework new antidiabetic drugs to support evidence-inmed medical insurance decision-making
YAN Feifei1，CHEN Jingyu1，CHEN Jiaran1，PAN Chen1，WANG Guohua2，GENG Jinsongl(1. Inmatics， School of 226001，China;2.National Diseases， Hospital，Capital ，Beijing lOo053，China)
ABSTRACTOBJECTIVEToestablishamulti-dimensional valueassssentframework newantidiabeticdrugs basedon multi-criteriadecisionanalysistheorythusprovidingatheoreticalframeworkandmethodologyevidence-inmedmedical insurancedecision-making.METHODSFirstly，multi-dimensionalevidencewassearchedandobtainedtoprovidereliabledata theestablishmentoftheframework.Secondlyintersoftheobtainedevidence，thvalueassessmentframeworkwaspreliarily constructed.Itsstructure，maincorecriteria，andcontextualciteriaweredeterminedtrough focusgroupdiscussion.inally，the crieriaandsub-riteriaoftheframeworkandtheirweightswerefurtherdetermined，reasonsinclusionofsub-riteriaandthe reasonablenessofrating scores were evaluated ......
您现在查看是摘要页，全文长 18167 字符。